{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T22:53:17Z","timestamp":1770763997473,"version":"3.50.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Access to pediatric medications remains a challenge in Albania, with significant implications for child health outcomes. Family doctors often encounter difficulties in prescribing and ensuring access to appropriate treatments. This study aimed to explore prescriber perspectives on the accessibility of pediatric medicines in Albania and to identify key barriers and facilitators affecting access. Between March and April 2024, semi-structured interviews were conducted with 18 family doctors working in primary healthcare centers in Durr\u00ebs. Data were analyzed deductively using the Pharmaceutical Value Chain framework, enhancing the methodological rigor of the analysis. Participants identified a range of perceived barriers, including regulatory constraints, pricing issues, limited medicine selection, procurement inefficiencies, and reimbursement challenges. Affordability emerged as a major concern, particularly for low-income families, and directly influenced prescribing behaviors. Shortages, especially of antibiotics frequently necessitated alternative treatments. While some pediatric medicines were available, concerns about the range, formulation, and quality persisted. Facilitators of access included effective patient counseling and clear communication between prescribers and pharmacists. Notably, policy, legislation, and health information technology were not identified as barriers by participants. This study highlights multiple perceived obstacles to pediatric medicine access as reported by prescribers. Findings underscore the need to enforce prescription regulations and update reimbursement policies for pediatric medicines, thereby informing future evidence-based policy interventions aimed at improving child health outcomes in Albania.<\/jats:p>","DOI":"10.1371\/journal.pgph.0005861","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:31:44Z","timestamp":1770748304000},"page":"e0005861","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Access to pediatric medicines in Albania: A qualitative study of family doctors\u2019 perceptions"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1471-3861","authenticated-orcid":true,"given":"Eriona","family":"Petro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-9818","authenticated-orcid":true,"given":"Hendrika A.","family":"van den Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8782-0698","authenticated-orcid":true,"given":"Aukje K.","family":"Mantel-Teeuwisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harallamb","family":"Martopullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7677-8589","authenticated-orcid":true,"given":"Iris R.","family":"Joosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8559-9168","authenticated-orcid":true,"given":"Fatima","family":"Suleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"pgph.0005861.ref001","unstructured":"World Health Organization. Operational principles for good pharmaceutical procurement. Geneva: World Health Organization; 2004. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/68571\/?sequence=1"},{"key":"pgph.0005861.ref002","unstructured":"World Health Organization. Essential medicines [Internet]. Geneva: World Health Organization; 2023 [cited 2025 Feb 04]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/essential-medicines"},{"key":"pgph.0005861.ref003","unstructured":"World Health Organization. Ten years in public health 2007\u20132017: report by Dr Margaret Chan, Director-General. Chapter: Access to medicines\u2014making market forces serve the poor [Internet]. Geneva: World Health Organization; 2017 [cited 2025 Jul 9]. Available from: https:\/\/www.who.int\/publications\/10-year-review\/chapter-medicines.pdf"},{"key":"pgph.0005861.ref004","unstructured":"World Health Organization. Targets of Sustainable Development Goal 3 [Internet]. Geneva: World Health Organization; [cited 2025 Feb 04]. Available from: https:\/\/www.who.int\/europe\/about-us\/our-work\/sustainable-development-goals\/targets-of-sustainable-development-goal-3"},{"key":"pgph.0005861.ref005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2016.12.032","article-title":"A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice","volume":"518","author":"RH Richey","year":"2017","journal-title":"Int J Pharm"},{"issue":"3","key":"pgph.0005861.ref006","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2471\/BLT.16.171967","article-title":"Medicines for children: flexible solid oral formulations","volume":"95","author":"ES Orubu","year":"2017","journal-title":"Bull World Health Organ"},{"issue":"2","key":"pgph.0005861.ref007","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1542\/peds.2013-3225","article-title":"Pediatric drug formulations: a review of challenges and progress","volume":"134","author":"V Ivanovska","year":"2014","journal-title":"Pediatrics"},{"issue":"1","key":"pgph.0005861.ref008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(68)80414-7","article-title":"Editorial comment: Therapeutic orphans","volume":"72","author":"H Shirkey","year":"1968","journal-title":"J Pediatr"},{"key":"pgph.0005861.ref009","first-page":"1","article-title":"The selection and use of essential medicines. Report of the WHO Expert Committee, October 2007 (including the Model List of Essential Medicines for Children)","volume":"950","author":"World Health Organization","year":"2008","journal-title":"Tech Rep Ser"},{"key":"pgph.0005861.ref010","volume-title":"Access to medicines and vaccines in the WHO European Region: Accountability report 2020","author":"World Health Organization Regional Office for Europe","year":"2020"},{"key":"pgph.0005861.ref011","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fpubh.2015.00207","article-title":"Paying out-of-pocket and informally for health care in Albania: The impoverishing effect on households","volume":"3","author":"SM Tomini","year":"2015","journal-title":"Front Public Health"},{"key":"pgph.0005861.ref012","volume-title":"Global spending on health: Weathering the storm 2020","author":"World Health Organization","year":"2020"},{"issue":"1","key":"pgph.0005861.ref013","doi-asserted-by":"crossref","first-page":"1699342","DOI":"10.1080\/16549716.2019.1699342","article-title":"Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators","volume":"13","author":"K Perehudoff","year":"2020","journal-title":"Glob Health Action"},{"key":"pgph.0005861.ref014","doi-asserted-by":"crossref","first-page":"100345","DOI":"10.1016\/j.lansea.2023.100345","article-title":"The availability of essential medicines in primary health centres in Indonesia: achievements and challenges across the archipelago","volume":"22","author":"RB Fanda","year":"2024","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"1","key":"pgph.0005861.ref015","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(24)00442-X","article-title":"Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis","volume":"13","author":"L Oldfield","year":"2025","journal-title":"Lancet Glob Health"},{"issue":"1","key":"pgph.0005861.ref016","doi-asserted-by":"crossref","first-page":"2372033","DOI":"10.1080\/20523211.2024.2372033","article-title":"Access to childhood cancer medicines in South Africa: a health systems analysis of barriers and enablers","volume":"17","author":"IR Joosse","year":"2024","journal-title":"J Pharm Policy Pract"},{"issue":"1","key":"pgph.0005861.ref017","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13104-024-06764-1","article-title":"A proposed analytical framework for qualitative evaluation of access to medicines from a health systems perspective","volume":"17","author":"IR Joosse","year":"2024","journal-title":"BMC Res Notes"},{"issue":"3","key":"pgph.0005861.ref018","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1542\/peds.2006-0051","article-title":"Family physicians in the child health care workforce: opportunities for collaboration in improving the health of children","volume":"118","author":"RL Phillips","year":"2006","journal-title":"Pediatrics"},{"key":"pgph.0005861.ref019","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.curtheres.2018.12.001","article-title":"Pediatric Drug Development: Challenges and Opportunities","volume":"90","author":"C Spadoni","year":"2018","journal-title":"Curr Ther Res Clin Exp"},{"key":"pgph.0005861.ref020","volume-title":"Addressing the Barriers to Pediatric Drug Development: Workshop Summary","author":"Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation","year":"2008"},{"issue":"1","key":"pgph.0005861.ref021","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/clinchem\/48.1.150","article-title":"Comparative costs of treating adults and children within selected diagnosis-related groups","volume":"48","author":"DS Young","year":"2002","journal-title":"Clin Chem"},{"key":"pgph.0005861.ref022","unstructured":"Republic of Albania. Law No. 105\/2014 on medicines and pharmaceutical service. Official Gazette No. 137. 2014."},{"key":"pgph.0005861.ref023","unstructured":"Ministry of Health and Social Protection. Order No. 501, dated 3 July 2018: On the approval of the list of medicines that may be dispensed without a medical prescription in the Republic of Albania. Official Gazette No. 103. 2018. Available from: https:\/\/akbpm.gov.al\/wp-content\/uploads\/2019\/07\/fz-2018-103-1.pdf"},{"key":"pgph.0005861.ref024","volume-title":"Can people afford to pay for health care? Evidence on financial protection in Albania","author":"World Health Organization","year":"2020"},{"issue":"10","key":"pgph.0005861.ref025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.37971","article-title":"Costs of Prescription Drugs for Children and Parental Adherence to Long-Term Medications","volume":"6","author":"JC Lauffenburger","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"pgph.0005861.ref026","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12992-022-00826-4","article-title":"What is the impact of intellectual property rules on access to medicines? A systematic review","volume":"18","author":"B Tenni","year":"2022","journal-title":"Glob Health"},{"key":"pgph.0005861.ref027","doi-asserted-by":"crossref","DOI":"10.1787\/9789264307391-en","volume-title":"Pharmaceutical innovation and access to medicines","author":"OECD","year":"2018"},{"issue":"9","key":"pgph.0005861.ref028","first-page":"1181","article-title":"Availability and licensing status of medicines for children in Serbia","volume":"73","author":"B Bo\u017ei\u0107","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"pgph.0005861.ref029","volume-title":"Strengthening affordable access to health care in the Western Balkans","author":"World Health Organization","year":"2024"},{"issue":"1","key":"pgph.0005861.ref030","doi-asserted-by":"crossref","first-page":"2290100","DOI":"10.1080\/20523211.2023.2290100","article-title":"Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children","volume":"17","author":"E Petro","year":"2023","journal-title":"J Pharm Policy Pract"},{"issue":"11","key":"pgph.0005861.ref031","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/thoraxjnl-2015-207349","article-title":"European protocols for the diagnosis and initial treatment of interstitial lung disease in children","volume":"70","author":"A Bush","year":"2015","journal-title":"Thorax"},{"issue":"1","key":"pgph.0005861.ref032","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12913-019-4359-8","article-title":"Assessing the impact of law enforcement to reduce over-the-counter (OTC) sales of antibiotics in low- and middle-income countries; a systematic literature review","volume":"19","author":"TG Jacobs","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"pgph.0005861.ref033","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/02813432.2012.712021","article-title":"Poor communication on patients\u2019 medication across health care levels leads to potentially harmful medication errors","volume":"30","author":"K Frydenberg","year":"2012","journal-title":"Scand J Prim Health Care"},{"issue":"1","key":"pgph.0005861.ref034","doi-asserted-by":"crossref","first-page":"2521425","DOI":"10.1080\/20523211.2025.2521425","article-title":"\u201cChallenges in pediatric medicine access in Albania: insights from community Pharmacists\u201d","volume":"18","author":"E Petro","year":"2025","journal-title":"J Pharm Policy Pract"},{"issue":"10067","key":"pgph.0005861.ref035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(16)31599-9","article-title":"Essential medicines for universal health coverage","volume":"389","author":"VJ Wirtz","year":"2017","journal-title":"Lancet"},{"key":"pgph.0005861.ref036","article-title":"Pricing of pharmaceuticals is becoming a major challenge for health systems","volume":"368","author":"SG Morgan","year":"2020","journal-title":"BMJ"},{"key":"pgph.0005861.ref037","unstructured":"World Health Organization. Affordability and pricing. [cited 2023 Oct 6]. Available from: https:\/\/www.who.int\/teams\/health-product-and-policy-standards\/medicines-selection-ip-and-affordability\/affordability-pricing"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:31:51Z","timestamp":1770748311000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005861"}},"subtitle":[],"editor":[{"given":"Olivier J","family":"Wouters","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0005861","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}